Molecular Formula | C19H30ClNO |
Molar Mass | 323.9 |
Melting Point | 159-164 °C |
Solubility | Chloroform (Slightly), Methanol (Slightly), Water (Slightly) |
Appearance | Solid |
Color | White to Off-White |
Storage Condition | 2-8°C |
In vivo study | Procyclidine widely used as anti-parkinsonian agents because of their anti-cholinergic action, is also known to have NMDA antagonist properties. Unlike other NMDA antagonists, these agents-because of their anti-cholinergic action-are devoid of neurotoxic side effects. Procyclidine alleviates thermal hyperalgesia in a dose dependent manner; when a marginally effective dose of the agent is combined with an ineffective dose of an alpha(2) adrenergic agonist (Clonidine or Guanabenz), the combination therapy provides effective and long-lasting relief from neuropathic pain. |
Hazard Symbols | Xn - Harmful![]() |
Risk Codes | 20/21/22 - Harmful by inhalation, in contact with skin and if swallowed. |
Safety Description | 36 - Wear suitable protective clothing. |
WGK Germany | 3 |
RTECS | UY1926000 |
HS Code | 2933997500 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.087 ml | 15.437 ml | 30.874 ml |
5 mM | 0.617 ml | 3.087 ml | 6.175 ml |
10 mM | 0.309 ml | 1.544 ml | 3.087 ml |
5 mM | 0.062 ml | 0.309 ml | 0.617 ml |